We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Booking.com
BKNG
$161B
| $540M | 0.76% |
6,703,425
-1,420,750
| -17% | -$108M |
|
27
Lowe's Companies
LOW
$125B
| $539M | 0.75% |
2,704,721
+273,884
| +11% | +$54.7M |
|
|
28
Vale
VALE
$62.6B
| $529M | 0.74% |
31,188,702
+15,047,063
| +93% | +$226M |
|
29
Intel
INTC
$513B
| $524M | 0.73% |
19,843,312
+5,995,350
| +43% | +$167M |
|
30
Rio Tinto
RIO
$164B
| $524M | 0.73% |
7,354,532
+1,422,509
| +24% | +$89.4M |
|
31
Shell
SHEL
$245B
| $515M | 0.72% |
9,039,456
-2,882,560
| -24% | -$159M |
|
|
32
General Motors
GM
$76.8B
| $497M | 0.69% |
14,763,488
+7,115,861
| +93% | +$263M |
|
33
GSK
GSK
$106B
| $494M | 0.69% |
14,044,350
+5,998,831
| +75% | +$200M |
|
34
Altria Group
MO
$114B
| $487M | 0.68% |
10,663,988
+1,187,135
| +13% | +$53.8M |
|
35
Citigroup
C
$226B
| $462M | 0.65% |
10,211,288
-888,121
| -8% | -$40.3M |
|
36
Elevance Health
ELV
$85.5B
| $461M | 0.64% |
897,805
-164,075
| -15% | -$83.3M |
|
37
O'Reilly Automotive
ORLY
$76.3B
| $456M | 0.64% |
8,111,910
-427,425
| -5% | -$23M |
|
38
Ulta Beauty
ULTA
$24.3B
| $447M | 0.63% |
953,617
+254,505
| +36% | +$110M |
|
|
ATVI
39
DELISTED
Activision Blizzard
ATVI
| $445M | 0.62% |
5,811,588
+2,346,136
| +68% | +$174M |
|
40
Petrobras
PBR
$116B
| $444M | 0.62% |
41,681,461
-1,662,357
| -4% | -$20.1M |
|
41
McKesson
MCK
$101B
| $425M | 0.59% |
1,132,207
+92,338
| +9% | +$34.4M |
|
42
Capital One
COF
$134B
| $424M | 0.59% |
4,564,819
-402,201
| -8% | -$39.5M |
|
43
Becton Dickinson
BDX
$48.2B
| $419M | 0.59% |
1,645,725
+659,013
| +67% | +$156M |
|
44
Hilton Worldwide
HLT
$71.5B
| $404M | 0.57% |
3,198,656
-499,799
| -14% | -$65.9M |
|
|
FISV
45
Fiserv Inc
FISV
$27.9B
| $395M | 0.55% |
3,912,415
+693,193
| +22% | +$69M |
|
46
Boston Scientific
BSX
$71.5B
| $392M | 0.55% |
8,480,978
+633,546
| +8% | +$27.4M |
|
47
Accenture
ACN
$108B
| $390M | 0.55% |
1,461,770
-221,120
| -13% | -$61.2M |
|
48
HCA Healthcare
HCA
$89.5B
| $384M | 0.54% |
1,602,293
-420,870
| -21% | -$94.3M |
|
49
Palo Alto Networks
PANW
$297B
| $379M | 0.53% |
5,438,884
-230,342
| -4% | -$18.5M |
|
50
AutoZone
AZO
$51.1B
| $376M | 0.53% |
152,505
-5,133
| -3% | -$12.4M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.